Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ ASX Shares
Why I would invest $20,000 into these top ASX shares
Record Highs
Is the CSL share price worth close to $400 a pop?
⏸️ ASX Shares
Is the ResMed share price in the buy zone?
Share Market News
This ASX healthcare share skyrocketed last week. Should you invest?
Growth Shares
3 stellar ASX growth shares to buy in February
⏸️ Best ASX Shares
Happy Australia Day!
Share Market News
3 ASX 100 healthcare shares to buy and hold beyond 2022
Share Market News
3 top ASX growth shares to diversify your portfolio
Share Market News
2 leading ASX healthcare shares that should be on your radar
⏸️ ASX Shares
Why these ASX healthcare shares could be long-term market beaters
Share Gainers
Why this top ASX dividend stock is climbing higher today
Share Market News
ASX 200 breaks through the 7,000 points level
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
